ANXA1 and stroke disorder: Therefore, the objective of this current study was to use pharmacological and genetic approaches together with a photoactivation thrombosis (light/dye) model to test the hypothesis that targeting the AnxA1/FPR-pathway protects the cerebral microvascular system against inflammation-induced microvascular thrombosis in co-morbidities susceptible to stroke.